DTAN - ETF AI Analysis

Top Page

Sparkline International Intangible Value ETF (DTAN)

Rating:67Neutral

Price Target:―

DTAN, the Sparkline International Intangible Value ETF, has a solid overall rating driven mainly by high-quality global leaders like Novartis, Toyota, and AstraZeneca, which show strong financial health, positive earnings outlooks, and generally supportive technical trends. These strengths are partly offset by valuation concerns and signs of potential overvaluation or overbought conditions in several key holdings such as Roche, L’Oreal, Siemens Energy, and Sony, which can limit upside and add risk. The main risk factor is that many top positions share this theme of rich valuations and some technical caution, which could make the fund more sensitive to market pullbacks.

Positive Factors

Strong Leading Holdings

Several of the largest positions, including major health care and industrial names, have shown strong gains this year, helping support the fund’s overall results.

Global Diversification

Holdings spread across Japan, the U.S., Europe, and other regions reduce reliance on any single country’s economy.

Balanced Sector Mix

Exposure to health care, industrials, consumer cyclical, and technology provides a mix of defensive and growth-oriented sectors.

Negative Factors

Moderate Expense Ratio

The fund’s fee is not especially low, which can slightly reduce long-term returns compared with cheaper ETFs.

Recent Weak Overall Performance

Despite some strong individual stocks, the ETF’s recent year-to-date and one-month performance has been slightly negative.

Underperforming Top Holdings

A few sizable positions, such as certain U.K. energy and Japanese technology names, have shown weak performance, which can drag on the fund.

DTAN vs. SPDR S&P 500 ETF (SPY)

AUM20.09M

RegionGlobal Ex-U.S.

Expense Ratio0.55%

Beta0.77

IssuerSparkline

Inception DateSep 09, 2024

Dividend Yield1.5%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume8,287

30 Day Avg. Volume4,990

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

36.46

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering118

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DTAN Summary

The Sparkline International Intangible Value ETF (DTAN) invests in companies around the world that are strong in “intangible” assets like brands, patents, and innovation, rather than just factories or hard assets. It doesn’t track a specific index, but follows a theme of international value stocks built on these modern strengths. The fund holds well-known names such as Toyota and Sony, along with global healthcare and industrial leaders. Someone might invest for international diversification and long-term growth tied to strong brands and research. A key risk is that the share price can rise or fall with global stock markets and foreign economies.

How much will it cost me?The Sparkline International Intangible Value ETF (DTAN) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed, focusing on companies with strong intangible assets, which requires more research and expertise.

What would affect this ETF?The Sparkline International Intangible Value ETF (DTAN) could benefit from global economic growth and increased demand for innovative companies leveraging intangible assets, such as intellectual property and brand strength, particularly in sectors like Health Care and Technology. However, it may face challenges from rising interest rates, which can impact the valuation of growth-focused companies, and geopolitical tensions or regulatory changes in the international markets where its top holdings, like Roche and Novartis, operate.

DTAN Top 10 Holdings

DTAN leans heavily on non-U.S. health care and industrial champions, with Roche and Novartis acting as steady engines of growth as their shares keep rising. Siemens and Hitachi add industrial and tech flavor, also climbing and giving the fund a solid backbone, while Siemens Energy has been a standout, helping power recent gains. On the softer side, AstraZeneca has been more mixed and Sony is clearly lagging, putting a small drag on returns. Overall, this is a global ex-U.S. play anchored in health care, industrials, and consumer brands.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ROG	Roche Holding AG	3.86%	$776.33K	CHF294.84B	47.36%	73 Outperform
NOVN	Novartis AG	3.60%	$722.39K	CHF242.43B	30.85%	80 Outperform
7203	Toyota Motor	2.96%	$595.38K	¥48.61T	34.33%	80 Outperform
AZN	AstraZeneca	2.91%	$585.40K	£240.98B	31.92%	80 Outperform
SIE	Siemens	2.88%	$578.92K	€191.01B	9.25%	74 Outperform
OR	L'Oreal	2.73%	$548.06K	€210.07B	16.59%	71 Outperform
ENR	Siemens Energy	2.60%	$522.52K	€141.97B	207.87%	72 Outperform
6758	Sony	2.51%	$503.63K	¥21.22T	-15.54%	73 Outperform
SHEL	Shell (UK)	2.50%	$501.69K	£165.51B	9.69%	73 Outperform
6501	Hitachi,Ltd.	2.34%	$470.73K	¥22.44T	17.72%	77 Outperform

DTAN Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

31.95

Positive

100DMA

31.04

Positive

200DMA

29.78

Positive

Market Momentum

MACD

0.40

Negative

RSI

57.66

Neutral

STOCH

53.81

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DTAN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.70, equal to the 50-day MA of 31.95, and equal to the 200-day MA of 29.78, indicating a bullish trend. The MACD of 0.40 indicates Negative momentum. The RSI at 57.66 is Neutral, neither overbought nor oversold. The STOCH value of 53.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DTAN.

DTAN Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DTAN	―	―	$20.09M	0.55%	―
JDVI	―	―	$59.37M	0.69%	―
AADR	―	―	$55.53M	1.09%	―
PJIO	―	―	$31.45M	0.90%	―
ABLG	―	―	$23.69M	0.54%	―
VNIE	―	―	$9.16M	0.60%	―

Performance Comparison

DTAN

Sparkline International Intangible Value ETF

33.09

6.80

25.87%

JDVI

John Hancock Disciplined Value International Select ETF

―

AADR

AdvisorShares Dorsey Wright ADR ETF

―

PJIO

PGIM Jennison International Opportunities ETF

―

ABLG

Abacus Fcf International Leaders Etf

―

VNIE

Vontobel International Equity Active ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents